Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

The FDA has cleared Iterum’s oral an­tibi­ot­ic for cer­tain pa­tients with un­com­pli­cat­ed uri­nary tract in­fec­tions (uUTIs) who have lim­it­ed or no al­ter­na­tive oral op­tions. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER